|
ý
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
|
Delaware
|
|
20-2650200
|
|
(State
or other jurisdiction of
incorporation
or organization)
|
|
(I.R.S.
Employer Identification No.)
|
|
|
|
|
|
360
Madison Avenue, 21st
Floor
New
York, New York
|
|
10017
|
|
(Address
of principal executive
offices)
|
|
(Zip
Code)
|
|
PART I
- FINANCIAL INFORMATION
|
|
|
Item
1. Financial Statements
|
3
|
|
Balance
Sheets
|
3
|
|
Statements
of Operations
|
4
|
|
Statement
of Cash Flows
|
5
|
|
Notes
to Consolidated Financial Statements
|
6-10
|
|
Item
2. Management’s Discussion and Analysis of Financial Condition and Results
of Operations
|
11
|
|
Item
3. Quantitative and Qualitative Disclosures about Market
Risk
|
12
|
|
Item
4. Controls and Procedures
|
13
|
|
PART II
- OTHER INFORMATION
|
|
|
Item
1. Legal Proceedings
|
14 |
|
Item
2. Unregistered Sales of Equity Securities and Use of
Proceeds
|
14
|
|
Item
3. Defaults Upon Senior Securities
|
14 |
|
Item
4. Submission of Matters to a Vote of Security
Holders
|
14 |
|
Item
5. Other Information
|
14 |
|
Item
6. Exhibits
|
14
|
|
SIGNATURES
|
15
|
|
June
30, 2006
|
March
31, 2006
|
||||||
|
ASSETS
|
(Restated)
|
||||||
|
Current
Assets:
|
|||||||
|
Cash
and cash equivalents
|
$
|
352,189
|
$
|
579,029
|
|||
|
Prepaid
expenses
|
52,873
|
72,488
|
|||||
|
Total
current assets
|
$
|
405,062
|
$
|
651,517
|
|||
|
Investments
held in Trust Account
|
51,496,984
|
51,108,343
|
|||||
|
Fixed
assets, net of accumulated depreciation
|
3,808
|
4,062
|
|||||
|
Total
assets
|
$
|
51,905,854
|
$
|
51,763,922
|
|||
|
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|||||||
|
Current
liabilities
|
|||||||
|
Accrued
expenses
|
$
|
57,268
|
$
|
90,310
|
|||
|
Taxes
payable
|
64,000
|
116,000
|
|||||
|
Derivative
liabilities
|
7,221,032
|
11,878,143
|
|||||
|
Total
current liabilities
|
$
|
7,342,300
|
$
|
12,084,453
|
|||
|
Common
stock, and changes in Trust Account value attributable to shares
subject
to possible redemption, 1,799,100 shares at $5.60 per
share
|
10,298,245
|
10,193,318
|
|||||
|
STOCKHOLDERS’
EQUITY
|
|||||||
|
Preferred
stock — $.0001 par value, 1,000,000 shares authorized; 0 shares issued and
outstanding
|
—
|
—
|
|||||
|
Common
stock — $.0001 par value, 50,000,000 shares authorized; 11,249,997 shares
issued and outstanding (which includes 1,799,100 shares subject to
possible redemption)
|
1,125
|
1,125
|
|||||
|
Additional
paid-in capital
|
33,947,234
|
33,947,234
|
|
||||
|
Retained
earnings, net income
|
316,950
|
(4,462,208
|
)
|
||||
|
Total
stockholders’ equity
|
34,265,309
|
29,486,151
|
|
||||
|
Total
liabilities and stockholders’ equity
|
$
|
51,905,854
|
$
|
51,763,922
|
|||
|
Three
Months
Ended
June
30, 2006
|
April
7, 2005
(Date
of
Inception)
Through
June
30, 2005
|
April
7, 2005
(Date
of
Inception)
Through
June
30, 2006
(Restated)
|
||||||||
|
Operating
costs
|
$
|
(101,567
|
)
|
$
|
(1,119
|
)
|
$
|
(317,660
|
)
|
|
|
Loss
from operations
|
(101,567
|
)
|
(1,119
|
)
|
(317,660
|
)
|
||||
|
Gain
(loss) from derivative liabilities
|
4,657,111
|
—
|
(94,748
|
)
|
||||||
|
Other
income—interest
|
392,541
|
310
|
1,132,643
|
|||||||
|
Income
before provision for income taxes
|
4,948,085
|
(809
|
)
|
720,235
|
||||||
|
Provision
for income taxes
|
(64,000
|
)
|
—
|
(180,000
|
)
|
|||||
|
Net
income
|
$
|
4,884,085
|
$
|
(809
|
)
|
$
|
540,235
|
|||
|
Weighted
average number of shares outstanding—basic
|
11,249,997
|
—
|
—
|
|||||||
|
Net
income per share—basic
|
$
|
0.43
|
—
|
|
—
|
|||||
|
Weighted
average number of shares outstanding—diluted
|
12,945,649
|
—
|
—
|
|||||||
|
Net
income per share—diluted
|
$
|
0.03
|
—
|
|
—
|
|||||
|
|
—
|
|||||||||
|
Pro
Forma Adjustment:
|
—
|
|||||||||
|
Interest
income attributable to common stock subject to possible redemption
(net of
taxes of $0)
|
$
|
(104,927
|
)
|
—
|
$
|
(223,285
|
)
|
|||
|
Pro
forma net income attributable to common stockholders not subject
to
possible redemption
|
$
|
4,779,158
|
—
|
$
|
316,950
|
|||||
|
Pro
forma weighted average number of shares outstanding, excluding shares
subject to possible redemption—basic
|
9,450,897
|
—
|
—
|
|||||||
|
Pro
forma net income per share, excluding shares subject to possible
redemption—basic
|
$
|
0.51
|
—
|
|
—
|
|||||
|
Pro
forma weighted average number of shares outstanding, excluding shares
subject to possible redemption—diluted
|
11,146,549
|
—
|
—
|
|||||||
|
Pro
forma net income per share, excluding shares subject to possible
redemption—diluted
|
$
|
0.03
|
—
|
|
—
|
|||||
|
Three
Months
Ended
June
30, 2006
|
April
7, 2005
(Date
of
Inception)
Through
June
30, 2005
|
April
7, 2005
(Date
of
Inception)
Inception
Through
June
30, 2006
(Restated)
|
||||||||
|
Cash
flows from operating activities:
|
||||||||||
|
Net
income
|
$
|
4,884,085
|
$
|
(809
|
)
|
$
|
540,235
|
|||
|
Adjustments
to reconcile net income to net cash provided by operating activities:
|
||||||||||
|
Depreciation
|
254
|
—
|
1,269
|
|||||||
|
Derivative
liabilities
|
(4,657,111
|
)
|
—
|
94,748
|
||||||
|
Changes
in operating assets and liabilities
|
—
|
|||||||||
|
Prepaid
expenses
|
19,615
|
70,000
|
(52,873
|
)
|
||||||
|
Accrued
expenses
|
(33,042
|
)
|
57,268
|
|||||||
|
Accrued
interest payable
|
(70,000
|
)
|
||||||||
|
Taxes
payable
|
(52,000
|
)
|
64,000
|
|||||||
|
Notes
payable to stockholder
|
87,018
|
|||||||||
|
Net
cash provided by operating activities
|
161,801
|
86,209
|
704,647
|
|||||||
|
Cash
flows from investing activities:
|
||||||||||
|
Investments held
in Trust Account
|
(388,641
|
)
|
—
|
(51,496,984
|
)
|
|||||
|
Purchase
of property and equipment
|
—
|
(5,077
|
)
|
|||||||
|
Net
cash used in investing activities
|
(388,641
|
)
|
—
|
(51,502,061
|
)
|
|||||
|
Cash
flows from financing activities:
|
||||||||||
|
Issuance
of stock
|
—
|
—
|
51,148,503
|
|||||||
|
Proceeds
from notes payable to stockholder
|
—
|
—
|
150,000
|
|||||||
|
Repayment
of note payable to stockholder
|
—
|
—
|
(150,000
|
)
|
||||||
|
Proceeds
from sale of common stock to founders
|
—
|
(9,375
|
)
|
1,000
|
||||||
|
Proceeds
from issuance of representative’s option
|
—
|
—
|
100
|
|||||||
|
Net
cash provided by financing activities
|
—
|
(9,375
|
)
|
51,149,603
|
||||||
|
Net
increase in cash and cash equivalents
|
(226,840
|
)
|
76,834
|
352,189
|
||||||
|
Cash
and cash equivalents—beginning of period
|
579,029
|
—
|
—
|
|||||||
|
Cash
and cash equivalents—end of period
|
$
|
352,189
|
$
|
76,834
|
$
|
352,189
|
||||
|
[1]
|
Cash
and cash equivalents:
The
Company considers all highly liquid
investments with original maturities of three months or less to be
cash
equivalents.
|
|
[2]
|
Investments
held in Trust Account:
At
June 30, 2006, the investments held in the
Trust Account consist of tax-exempt municipal money market funds,
and are
treated as trading securities and recorded at their market value.
The
excess of market over cost is included in interest income in the
accompanying statement of
operations.
|
|
[3]
|
Accounting
for Warrants and Derivative Instruments
Emerging
Issues Task Force issued EITF 00-19, “Accounting for Derivative Financial
Instruments Indexed to, and Potentially Settled in, a Company's
Own
Stock,” (“EITF 00-19”) requires freestanding contracts that are settled in
a company's own stock, including common stock warrants, to be designated
as an equity instrument, asset or a liability. In accordance with
EITF
00-19, the Company determined that the warrants issued in connection
with
the Offering should be classified as a derivative liability due
to the
absence in the warrant agreement of provisions addressing the exercise
of
the warrants in the absence of an effective registration statement.
Under
interpretations of applicable federal securities laws, the issuance
of
shares upon exercise of the warrants in the absence of an effective
registration statement could be deemed a violation of Section 5
of the
Securities Act of 1933, as amended. To address this issue, the
warrant
agreement requires that the Company file, and use best efforts
to cause to
be declared and keep effective, a registration statement covering
the
issuance of the shares underlying the warrants. However, the warrant
agreement fails to specify the remedies, if any, that would be
available
to warrantholders in the event there is no effective registration
statement covering the issuance of shares underlying the warrants.
Under
EITF 00-19, the registration of the common stock underlying the
warrants
is not within the Company's control. In addition, under EITF 00-19,
in the
absence of explicit provisions to the contrary in the warrant agreement,
the Company must assume that it could be required to settle the
warrants
on a net-cash basis, thereby necessitating the treatment of the
potential
settlement obligation as a liability.
Under
the provisions of EITF 00-19, a contract designated as an asset
or a
liability must be carried at fair value on a company’s balance sheet, with
any changes in fair value recorded in the company’s results of operations.
The fair value of these warrants is shown on the Company’s balance sheet
and the unrealized changes in the values of these derivatives are
shown in
the Company’s consolidated statement of operations as “Gain (loss) from
derivative liabilities.” The price for the warrants is quoted on the Over
the Counter Bulletin Board, consequently, the fair value of these
warrants
is estimated as the market price of a warrant at the end of each
period.
To the extent that the market price increases or decreases, the
Company’s
derivative liability will also increase or decrease, impacting
the
Company’s consolidated statement of operations.
As
described in Note C below, in connection with the Offering, the
Company
sold to the underwriters an option to purchase 450,000 units, each
of
which consists of one share of common stock and two warrants that
are
identical to the Company’s public warrants except for the exercise price.
The Company has determined that this option is a derivative that
also
contains an embedded derivative, the 900,000 warrants included
in the
units issuable upon exercise of the option. The Company considers
this
option to be an equity instrument, as the underlying units do not
need to
be registered prior to delivery. However, the shares issued upon
exercise
of the warrants included in the underlying units do require registration.
Statement
of Financial Accounting Standard (“SFAS”) No. 133, “Accounting for
Derivative Instruments and Hedging Activities,” as amended, requires all
derivatives to be recorded on the balance sheet at fair value.
Furthermore, paragraph 11(a) of SFAS No. 133 precludes contracts
issued or
held by a reporting entity that are both (1) indexed to its own
stock and
(2) classified as stockholders’ equity in its statement of financial
position from being treated as derivative instruments. Hence, the
option
to purchase 450,000 units and the warrants to purchase an additional
900,000 shares, the latter being the embedded derivative, are separately
valued and accounted for on the Company’s balance sheet. As such, the
option to purchase 450,000 units is considered an equity instrument,
as
the underlying shares do not need to be registered, and all other
criteria
in EITF 00-19 required for the instrument to be accounted for as
an equity
instrument have been fulfilled. While the warrants are indexed
to the
Company’s common stock, the fact that the shares underlying the warrants
require future registration in accordance with the warrant agreement
requires the Company to classify these instruments as a liability
in
accordance with EITF 00-19, paragraph 14.
The
Company performed a valuation of the option to purchase 450,000
units, and
then allocated its fair value to its two components, the underlying
450,000 units and the embedded warrant to purchase an additional
900,000
shares. The fair value of the unit purchase option at August 31,
2005 was
calculated, using the Black Scholes pricing model, at $1,873,367,
or $4.16
per unit, using an expected, life of five years, volatility of
92.5% and a
risk free interest rate of 3.87%. Because the Company has not consummated
the Business Combination, management derived the volatility estimate
based
on the average five-year historical stock prices for a representative
sample of 20 technology, media and telecommunications companies
with
market capitalizations below $500 million, which management believes
is a
reasonable benchmark to use in estimating the expected volatility
of the
units after the consummation of a Business Combination. Although
an
expected life of five years was used in this calculation, if the
Company
does not consummate a Business Combination within the prescribed
time
period and the Company liquidates, the option will become
worthless.
|
|
|
As
of June 30, 2006, the Company allocated $1,422,784 to the purchase
option
of 450,000 shares and $201,032 to the embedded warrants.
The
Company has determined the fair values of the option and the
embedded
warrants subsequent to the initial valuation thereof using the
Black
Scholes pricing model. Valuations derived from this model are
subject to
ongoing internal and external verification and review. The model
uses
market-sourced inputs such as interest rates, market prices and
volatilities. Selection of these inputs involves management’s judgment and
may impact net income. The Company continues to base its volatility
assumption on the five-year average historical stock prices of
the same
representative sample of 20 technology, media and telecommunications
companies as used in its initial valuation. The volatility factor
used in
Black Scholes has a significant effect on the resulting valuation
of the
derivative liabilities on the Company’s balance sheet. As of June 30,
2006, the volatility for the calculation of the embedded derivatives
was
approximated at 76.5%, and this volatility rate will likely change
in the
future.
|
|
[4]
|
Earnings
per common share:
Earnings
per share is computed by dividing net income attributable to common
stockholders by the weighted average number of common shares outstanding
for the period. Diluted net income per share is computed using the
weighted average number of shares outstanding adjusted per the incremental
shares attributed to outstanding options to purchase common
stock.
|
|
[5]
|
Use
of estimates:
The
preparation of financial statements in conformity with accounting
principles generally accepted in the United States of America
requires
management to make estimates and assumptions that affect the
reported
amounts of assets and liabilities and disclosure of contingent
assets and
liabilities at the date of the financial statements and the reported
amounts of revenues and expenses during the reporting period.
Actual
results could differ from those
estimates.
|
|
[6]
|
Income
taxes:
Deferred
income taxes are provided for the differences between the bases
of assets
and liabilities for financial reporting and income tax purposes.
A
valuation allowance is established when necessary to reduce
deferred tax
assets to the amount expected to be realized.
The
Company recorded a deferred income tax asset for the tax effect
of
start-up costs and temporary differences, aggregating approximately
$135,000. In recognition of the uncertainty regarding the ultimate
amount
of income tax benefits to be derived, the Company has recorded
a full
valuation allowance at June 30,
2006.
|
|
31.1
|
Section 302
Certification of Chief Executive Officer
|
|
31.2
|
Section 302
Certification of Chief Financial Officer
|
|
32.1
|
Section 906
Certification
|
|
AD.VENTURE
PARTNERS, INC.
|
||
| |
|
|
|
Date:
August 21, 2006
|
By: | /s/ Howard S. Balter |
|
Howard
S. Balter
Chairman
and Chief Executive
Officer
(Principal Executive Officer)
|
||
| |
|
|
| By: | /s/ Ilan M. Slasky | |
|
Ilan
M. Slasky
President
and Secretary (Principal Financial and Accounting
Officer)
|
||